Compare LYFT Inc (LYFT) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LYFT Inc vs Zoetis Inc — how do they compare? LYFT Inc trades at $15.2 (market cap $5.86B), while Zoetis Inc trades at $75.47 (market cap $31.95B). The key difference: Zoetis Inc is far larger — about 5.5× LYFT Inc's market cap, and Zoetis Inc pays a 2.78% dividend while LYFT Inc pays none. Which is the better fit depends on your goals.
| LYFT | ZTS | |
|---|---|---|
Market Cap | $5.86B | $31.95B |
Sector | Industrials | Health |
52-Week High | $24.57 | $156.76 |
52-Week Low | $12.65 | $71.91 |
Enterprise Value | $5.39B | $39.24B |
Dividend Yield | — | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lyft trades at $15.19, down 2.13% today, with a bullish technical signal from moving averages and ADX indicators. The stock shows strong fundamental improvement, with revenue growing to $6.32B in 2025 and net income surging to $2.84B, yielding a net margin of 43.82%. Recent developments include expansion into New York City's taxi market and a new CTO appointment. Valuation metrics appear attractive with a P/E of 2.26 and P/S of 0.98, below industry averages.
The outlook for Lyft is cautiously optimistic, supported by profitability turnaround and strategic expansions, but tempered by recent earnings misses and intense competition. Upside potential exists toward the consensus price target of $17.86, representing 17.6% upside from current levels. Key risks include competitive pressures from Uber, pricing transparency concerns, and execution risks in autonomous vehicle partnerships. Investor sentiment remains mixed with 37% buy ratings versus 58% hold recommendations.
Zoetis (ZTS) trades at $75.33, down 1.61% amid mixed technical signals and ongoing securities litigation. The stock shows strong fundamentals with a 28.03% net margin and 67.75% ROE, supported by consistent revenue growth from $8.1B in 2022 to $9.47B in 2025. Recent earnings beat expectations in Q3 and Q4 2025 but missed in Q1 2026, with Q2 results pending. Analyst consensus remains positive with a $101.43 price target, though technical indicators show neutral momentum near key support at $75.
The outlook for ZTS is cautiously optimistic given robust profitability and analyst support, but significant legal overhangs and recent earnings volatility present near-term risks. Long-term growth in animal health markets offers upside, yet investors should monitor litigation developments and Q2 earnings for directional cues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About LYFT Inc
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
